General Investor Information EBR Systems, page-328

Thanks again longreach …
This site says the first leadless dual chamber system was FDA approved in July 2023 - the Aveir from Abbott
https://cardiovascularbusiness.com/...-first-dual-chamber-leadless-pacemaker-system

https://www.abbott.com/corpnewsroom...stem-3-things-to-know-after-FDA-approval.html

According to the last EBR presentation the WiSE implant is substantially smaller which is good …. So I guess that would make EBR an ideal takeover candidate (despite what John McCutcheon said in one of the links you posted) .

This article from 18/07/24 says analysts have given Abbott, the Aveir developer (a diverse medical gadgets etc company ) an ‘outperform’ rating but no mention gets made of how many of those dual chamber units have been sold…
https://www.investing.com/news/comp...rform-rating-on-solid-q2-results-93CH-3525558

cheers